Atlas Trials

Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors

Clinical trial NCT02966691 · COMPLETED

Trial details

NCT number
NCT02966691
Sponsor
Vitadx
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2017-01-24
Primary completion
2020-12-31
Enrollment
1360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.